CD Antigen Cancer Therapy Market Size, Share & Trends Analysis Report by Type of CD Antigen Targeted (CD19, CD20, CD30, CD33, CD38, CD70, Other Types) by Therapy Type (Monoclonal Antibodies (mAbs), Antibody-Drug Conjugates (ADCs), Chimeric Antigen Receptor (CAR) T-cell Therapy, Bi-specific T-cell Engagers (BiTEs), Radioimmunotherapy, Immunotoxins) by Cancer Type (Leukemia, Lymphoma, Multiple Myeloma, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer Types) by End User (Hospitals, Specialty Clinics, Cancer Treatment Centers, Research Institutes) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2018 - 2023) & Forecast (2024 - 2032)
Report accessible by 1 user only